197 related articles for article (PubMed ID: 6685702)
21. Multidrug therapy in multibacillary leprosy; experience in an urban leprosy center.
Ramesh V; Misra RS; Saxena U
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):13-7. PubMed ID: 1602189
[TBL] [Abstract][Full Text] [Related]
22. The nose in lepromatous leprosy; bacteriological and histopathological studies of patients treated with dapsone monotherapy for varying periods of time.
Barton RP; Rees RJ; McDougall AC; Ellard GA
Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):58-67. PubMed ID: 7200473
[TBL] [Abstract][Full Text] [Related]
23. Dapsone resistant leprosy, the western Kenya experience.
Orege PA; Owili DM
Trop Geogr Med; 1985 Jun; 37(2):139-42. PubMed ID: 4035777
[TBL] [Abstract][Full Text] [Related]
24. Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL) patients during the first two to four years of DDS treatment.
Melsom R; Harboe M; Naafs B
Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):271-81. PubMed ID: 6754639
[TBL] [Abstract][Full Text] [Related]
25. [Relapses after multibacillary leprosy treatment].
Rodríguez G; Pinto R; Laverde C; Sarmiento M; Riveros A; Valderrama J; Ordóñez N
Biomedica; 2004 Jun; 24(2):133-9. PubMed ID: 15495593
[TBL] [Abstract][Full Text] [Related]
26. Two microbiological relapses in a patient with lepromatous leprosy.
Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
[TBL] [Abstract][Full Text] [Related]
27. Hansen's disease in Portugal: multibacillary patients treated between 1988 and 2003.
Medeiros S; Catorze MG; Vieira MR
J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):29-35. PubMed ID: 18713227
[TBL] [Abstract][Full Text] [Related]
28. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP
Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
[TBL] [Abstract][Full Text] [Related]
29. Operational study to monitor the regularity of dapsone intake by leprosy out-patients.
Kumar A; Balakrishnan S
Lepr India; 1983 Jul; 55(3):521-7. PubMed ID: 6656209
[TBL] [Abstract][Full Text] [Related]
30. Relapse rates in patients treated with dapsone monotherapy and combinations of dapsone and thiambutosine, thiacetazone, isoniazid and streptomycin in the pre-MDT era.
Smith TC; Richardus JH
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):353-8. PubMed ID: 7525795
[TBL] [Abstract][Full Text] [Related]
31. Bacterial clearance with WHO--recommended multidrug regimen for multibacillary leprosy.
Kishore BN; Shetty JN
Indian J Lepr; 1995; 67(3):301-8. PubMed ID: 8576609
[TBL] [Abstract][Full Text] [Related]
32. Rate of relapse in multibacillary patients after cessation of long-course dapsone monotherapy supplemented by a final supervised single dose of 1500 mg of rifampin.
Cartel JL; Naudin JC
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):215-9. PubMed ID: 8046260
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of multiple regimens in leprosy.
Ramu G; Sreevatsa ; Sengupta U; Desikan KV
Lepr India; 1981 Apr; 53(2):190-6. PubMed ID: 6166790
[TBL] [Abstract][Full Text] [Related]
34. Rate and time distribution of relapses in multibacillary leprosy.
Kurz XM; Declercq EE; Vellut CM
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):599-606. PubMed ID: 2778367
[TBL] [Abstract][Full Text] [Related]
35. Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment.
Warndorff van Diepen T; Mengistu G
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):189-97. PubMed ID: 2410520
[TBL] [Abstract][Full Text] [Related]
36. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
[TBL] [Abstract][Full Text] [Related]
37. Association between regularity in dapsone (DDS) treatment and development of deformity.
Radhakrishna S; Nair NG
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):425-34. PubMed ID: 3655458
[TBL] [Abstract][Full Text] [Related]
38. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
Kamal R; Dayal R; Katoch VM; Katoch K
Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
[TBL] [Abstract][Full Text] [Related]
39. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
Vijayakumaran P; Manimozhi N; Jesudasan K
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of two regimens of combined chemotherapy of one year duration in multibacillary leprosy. Results after four and five years' follow-up.
Pattyn SR; André PS; Ferracci C; Baquillon G
Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):297-303. PubMed ID: 6541198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
